Literature DB >> 7540655

Expression of functional CD40 by vascular endothelial cells.

D Hollenbaugh1, N Mischel-Petty, C P Edwards, J C Simon, R W Denfeld, P A Kiener, A Aruffo.   

Abstract

The interaction between activated vascular endothelium and T cells has been shown to play an important role in the recruitment and activation of T cells at sites of inflammation. Here we report the expression of CD40 by vascular endothelial cells and its regulation by inflammatory agents. Using the soluble recombinant CD40 ligand, sgp39, we show that the interaction of CD40 with its ligand can lead to endothelial cell activation, which in turn leads to leukocyte adhesion. This adhesion is partly mediated by the expression of E-selectin. In addition to E-selectin expression, sgp39 induces the expression of intercellular adhesion molecule 1 and augments the tumor necrosis factor alpha-induced expression of vascular cell adhesion molecule 1. The effects of sgp39 on endothelial cells can be blocked with anti-gp39 monoclonal antibody (mAb), anti-CD40 mAb, or soluble CD40. Staining of tissues from healthy human skin using anti-CD40 mAb showed very weak expression of CD40 by the endothelium, while skin involved in inflammatory disease showed marked upregulation of CD40 expression. These studies suggest that interactions between cell surface proteins expressed by activated T cells with their receptors on vascular endothelium can stimulate the vasculature at sites of inflammation and may be involved in normal inflammatory responses and in inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540655      PMCID: PMC2192103          DOI: 10.1084/jem.182.1.33

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts.

Authors:  D M Briscoe; F J Schoen; G E Rice; M P Bevilacqua; P Ganz; J S Pober
Journal:  Transplantation       Date:  1991-02       Impact factor: 4.939

2.  Ability of human T lymphocytes to adhere to vascular endothelial cells and to augment endothelial permeability to macromolecules is linked to their state of post-thymic maturation.

Authors:  N K Damle; L V Doyle
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

3.  Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes.

Authors:  L S Young; C W Dawson; K W Brown; A B Rickinson
Journal:  Int J Cancer       Date:  1989-05-15       Impact factor: 7.396

4.  Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50.

Authors:  E A Clark; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. A comparison with IL-4-mediated signaling.

Authors:  J Gordon; M J Millsum; G R Guy; J A Ledbetter
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

6.  Synergistic interaction between interleukin 4 and anti-Bp50 (CDw40) revealed in a novel B cell restimulation assay.

Authors:  J Gordon; M J Millsum; G R Guy; J A Ledbetter
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

7.  Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).

Authors:  J A Ledbetter; G Shu; M Gallagher; E A Clark
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

8.  A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes.

Authors:  S Paulie; B Ehlin-Henriksson; H Mellstedt; H Koho; H Ben-Aissa; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

9.  Isolated human follicular dendritic cells display a unique antigenic phenotype.

Authors:  F Schriever; A S Freedman; G Freeman; E Messner; G Lee; J Daley; L M Nadler
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

10.  CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.

Authors:  K L Bennett; D G Jackson; J C Simon; E Tanczos; R Peach; B Modrell; I Stamenkovic; G Plowman; A Aruffo
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

View more
  83 in total

1.  Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

Authors:  N S Kenyon; M Chatzipetrou; M Masetti; A Ranuncoli; M Oliveira; J L Wagner; A D Kirk; D M Harlan; L C Burkly; C Ricordi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis.

Authors:  Laurence M Howard; Serge Ostrovidov; Cassandra E Smith; Mauro C Dal Canto; Stephen D Miller
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 3.  Therapeutic potential for blockade of the CD40 ligand, gp39.

Authors:  J E Buhlmann; R J Noelle
Journal:  J Clin Immunol       Date:  1996-03       Impact factor: 8.317

4.  Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice.

Authors:  Giada Ingoglia; Ayla Yalamanoglu; Marc Pfefferlé; Irina L Dubach; Christian A Schaer; Kristyna Valkova; Kerstin Hansen; Nadja Schulthess; Rok Humar; Dominik J Schaer; Florence Vallelian
Journal:  Blood Adv       Date:  2020-06-23

5.  Association of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients.

Authors:  N Katakami; H Kaneto; M Matsuhisa; T Miyatsuka; K Sakamoto; D Kawamori; K Yoshiuchi; Y Nakamura; K Kato; K Yamamoto; K Kosugi; M Hori; Y Yamasaki
Journal:  Diabetologia       Date:  2006-05-12       Impact factor: 10.122

6.  TGF-beta1 null mutation leads to CD154 upregulated expression in affected tissues.

Authors:  T Nakabayashi; K M Sakata; A Sakata; L Kong; C A Lau; J J Letterio; N Vela-Roch; N Talal; H Dang
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

Review 7.  Platelets and innate immunity.

Authors:  John W Semple; John Freedman
Journal:  Cell Mol Life Sci       Date:  2009-12-18       Impact factor: 9.261

Review 8.  Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation.

Authors:  R S Smith; T J Smith; T M Blieden; R P Phipps
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 9.  Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases?

Authors:  Pier Luigi Meroni; Cristina Luzzana; Donatella Ventura
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

10.  Human immunodeficiency virus (HIV) type 1 Vpu induces the expression of CD40 in endothelial cells and regulates HIV-induced adhesion of B-lymphoma cells.

Authors:  Winnie W Henderson; Rebecca Ruhl; Paul Lewis; Matthew Bentley; Jay A Nelson; Ashlee V Moses
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.